Global Medical REIT Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015
Revenue	141.05	137.28	115.94	93.73	70.73	53.19	30.34	8.21	2.06
Revenue Growth (YoY)	2.74%	18.41%	23.69%	32.53%	32.96%	75.30%	269.55%	298.21%	-
Gross Profit	141.05	137.28	115.94	93.73	70.73	53.19	30.34	8.21	2.06
Selling, General & Admin	16.85	16.55	16.45	11.94	6.54	5.54	5.49	4.22	0.43
Other Operating Expenses	86.26	82.27	62.51	65.61	37.13	25.79	17.51	6.21	1.73
Operating Expenses	103.11	98.81	78.97	77.55	43.67	31.33	23	10.43	2.15
Operating Income	37.94	38.47	36.97	16.18	27.06	21.86	7.35	-2.21	-0.09
Interest Expense / Income	30.89	25.23	19.7	18.68	17.47	14.98	7.44	4.14	1.52
Other Expense / Income	-13.57	-5.9	-0.35	-0.57	0.35	-6.6	-0.05	-	-
Pretax Income	20.61	19.14	17.62	-1.93	9.23	13.49	-0.04	-6.35	-1.61
Net Income	20.61	19.14	17.62	-1.93	9.23	13.49	-0.04	-6.35	-1.61
Preferred Dividends	5.82	5.82	5.82	5.82	5.82	5.82	1.71	0	0
Net Income Common	14.79	13.32	11.8	-7.75	3.41	7.67	-1.75	-6.35	-1.61
Net Income Growth	11.04%	12.88%	-	-	-55.50%	-	-	-	-
Shares Outstanding (Basic)	66	65	61	46	34	22	20	9	0
Shares Outstanding (Diluted)	66	65	61	46	34	22	20	9	0
Shares Change	0.13%	7.95%	31.10%	36.59%	54.13%	12.00%	110.89%	3620.80%	-
EPS (Basic)	0.23	0.20	0.19	-0.17	0.10	0.35	-0.09	-0.68	-6.44
EPS (Diluted)	0.23	0.20	0.19	-0.17	0.10	0.35	-0.09	-0.68	-6.44
EPS Growth	15.00%	5.26%	-	-	-71.43%	-	-	-	-
Free Cash Flow	137.31	-61.67	-125.64	-184.09	-221.75	-126.74	-239.98	-152.66	-32.41
Free Cash Flow Per Share	2.10	-0.94	-2.07	-3.98	-6.55	-5.77	-12.23	-16.41	-129.65
Dividend Per Share	0.840	0.840	0.820	0.800	0.800	0.800	0.800	0.400	-
Dividend Growth	0%	2.44%	2.50%	0%	0%	0%	100.00%	-	-
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	26.89%	28.02%	31.89%	17.26%	38.26%	41.10%	24.22%	-26.96%	-4.36%
Profit Margin	10.49%	9.70%	10.18%	-8.27%	4.82%	14.42%	-5.77%	-77.37%	-78.03%
Free Cash Flow Margin	97.35%	-44.92%	-108.37%	-196.40%	-313.54%	-238.26%	-790.85%	-1859.24%	-1571.87%
EBITDA	92.77	84.38	71.14	43.5	45.88	42.11	15.33	0.12	0.57
EBITDA Margin	65.77%	61.46%	61.36%	46.41%	64.87%	79.16%	50.51%	1.47%	27.64%
Depreciation & Amortization	41.27	40.01	33.83	26.75	19.18	13.64	7.93	2.34	0.66
EBIT	51.51	44.37	37.32	16.76	26.71	28.47	7.4	-2.21	-0.09
EBIT Margin	36.52%	32.32%	32.19%	17.88%	37.76%	53.51%	24.38%	-26.96%	-4.36%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).